Thomas Unger1, Björn Dahlöf. Show Affiliations » 1. Center for Cardiovascular Research (CCR), Institute of Pharmacology, Charité - University Medicine Berlin, Germany. thomas.unger@charite.de
Abstract
Entities: Gene
Mesh: See more » Administration, OralAngiotensin II Type 1 Receptor Blockers/pharmacologyAngiotensin II Type 1 Receptor Blockers/therapeutic useAngiotensin II Type 2 Receptor BlockersAnimalsCardiovascular Diseases/drug therapyHumansPeptides/pharmacologyReceptor, Angiotensin, Type 2/agonistsSulfonamides/administration & dosageSulfonamides/pharmacologySulfonamides/therapeutic useThiophenes/administration & dosageThiophenes/pharmacologyThiophenes/therapeutic use
Substances: See more » Angiotensin II Type 1 Receptor BlockersAngiotensin II Type 2 Receptor BlockersN-butyloxycarbonyl-3-(4-imidazol-1-ylmethylphenyl)-5-isobutylthiophene-2-sulfonamidePeptidesReceptor, Angiotensin, Type 2SulfonamidesThiophenes
Year: 2009 PMID: 19861350 DOI: 10.1177/1470320309347792
Source DB: PubMed Journal: J Renin Angiotensin Aldosterone Syst ISSN: 1470-3203 Impact factor: 1.636